Category Archives: COVID-19

Vaccines Fight the Triple Threat

Covered employees will be encouraged to talk to their doctors about whether vaccines against this season’s triple threat – COVID, the flu and respiratory syncytial virus (RSV) – are the right choice for them. Early next week, this email will … Continue reading

Posted in Cost Savings, COVID-19, Health and Wellness, Pharmacy, Trustmark Small Business Benefits | Leave a comment

Standard Time Frames to Return in July

In response to the COVID pandemic, the federal government temporarily extended a number of health benefit plan deadlines. Time frames for certain provisions provided under all self-funded health plans administered by Star Marketing and Administration, Inc., will return to standard … Continue reading

Posted in COVID-19, Trustmark Small Business Benefits | Leave a comment

COVID Benefit Changes Set for May

Posted on April 26, 2023 | Leave a comment | Edit Changes to COVID-19 coverage will occur on May 12, 2023, when federal requirements established under the Public Health Emergency (PHE) will no longer apply to health benefit plans. The PHE was established in March 2020 … Continue reading

Posted in COVID-19 | Leave a comment

Most CVS Pharmacists Can Now Prescribe Antiviral Pill to Treat COVID

On Nov. 8, 2022, the following email was sent to employers that offer major medical, certain preventive-only or limited medical self-funded health benefit plans administered by Star Marketing and Administration Inc., except where there are exclusions. The program described below … Continue reading

Posted in COVID-19, Health and Wellness, Trustmark Small Business Benefits | Leave a comment

Updates on Access to At-Home COVID Tests

Updates on how covered employees can access over-the-counter, at-home COVID tests have been announced. Effective today, Aug. 1, 2022, the changes affect employees covered by major medical, limited medical and some preventive-only plans administered by Star Marketing and Administration, Inc. … Continue reading

Posted in COVID-19 | Leave a comment

How Employees Can Get At-Home COVID Tests

Employees covered under self-funded, group health plans administered by Star Marketing and Administration, Inc., now have two ways to save on FDA-approved, at-home COVID-19 tests that do not require a doctor’s order. Visit the Regulatory Updates blog for more information.

Posted in COVID-19, Trustmark Small Business Benefits | Leave a comment

Reminder: Plan Administrators/COBRA Administrators Required to Remind Individuals About When COBRA Premium Assistance Ends

Plan administrators/COBRA administrators are required to notify assistance eligible individuals that COBRA premium assistance made available through the American Rescue Plan Act (ARPA) expires soon, the date of expiration, and that the individual may be eligible for coverage without any … Continue reading

Posted in COVID-19 | Leave a comment

Updates: New Temporary COBRA Subsidy Under the American Rescue Plan Act

Please see updates regarding links to new COBRA notices, coverage and an FAQ from the federal government. The American Rescue Plan Act (ARPA) requires that from April 1, 2021, through Sept. 30, 2021, certain COBRA qualified beneficiaries who are referred … Continue reading

Posted in Compliance, COVID-19, Trustmark Small Business Benefits | Leave a comment

Temporary COBRA Subsidy Provided Under the American Rescue Plan Act

The American Rescue Plan Act (ARPA) requires that from April 1, 2021, through Sept. 30, 2021, certain COBRA qualified beneficiaries who are referred to as “assistance eligible individuals” who elect or will elect COBRA are not charged any amounts for … Continue reading

Posted in Compliance, COVID-19 | Leave a comment

More Relief Available for Small Businesses

A new federal law increases the lending authority of the Paycheck Protection Program (PPP) by $7.25 billion. The PPP was designed to help small businesses keep workers on the payroll during the COVID-19 pandemic. The provision increasing its lending authority was … Continue reading

Posted in COVID-19 | Leave a comment